Lurakem Study Quiz Link
-
For which indication was the recent approval of Lurasidone from USFDA?
-
For schizophrenia aged between 13-17
-
For Bipolar disorder & schizophrenia aged between 13-17
-
For adolescent schizophrenia aged between 13-17
-
For Bipolar depression aged between 13-17
-
This quiz assesses knowledge on Lurasidone, focusing on its USFDA approval for adolescent schizophrenia, long-term safety, and efficacy studies.
Quiz Preview
- 2.
In which journal(Name of the journal) the lurasidone safety & effectiveness got proved in 2 years of study?
-
International journal of bipolar disorder 2017
-
Bipolar journal psychiatry & mood disorders 2016
-
BPD psychiatry 2017
-
Indian Journal of Psychiatry disorders 2016
Correct Answer
A. International journal of bipolar disorder 2017Explanation
The correct answer is the International Journal of Bipolar Disorder 2017.Rate this question:
-
- 3.
In the long term use of lurasidone trail over 2 years, change in weight gain, BMI,glycemic indices & prolactin with lurasidone were not meaningful?
-
True
-
False
Correct Answer
A. TrueExplanation
The statement suggests that in a long-term study of lurasidone, there were no significant changes observed in weight gain, BMI, glycemic indices, and prolactin levels. This implies that the use of lurasidone over a period of 2 years did not have a meaningful impact on these factors. Therefore, the answer "True" indicates that the statement is correct.Rate this question:
-
- 4.
In this safety & efficacy trail of 2 years with lurasidone discontinuation due to adverse events with lurasidone was relatively low as 6.6% ?
-
True
-
False
Correct Answer
A. TrueExplanation
The explanation for the given correct answer is that in a safety and efficacy trial conducted over a period of 2 years with lurasidone, the discontinuation rate due to adverse events was relatively low at 6.6%. This suggests that the participants in the trial were able to tolerate the medication well and did not experience significant adverse effects that would require them to discontinue its use. Therefore, the statement that discontinuation due to adverse events with lurasidone was relatively low as 6.6% is true.Rate this question:
-
- 5.
In the safety & efficacy study of lurasidone in long term, Lurasidone has high relapse rates.?
-
True
-
False
Correct Answer
A. FalseExplanation
The statement "Lurasidone has high relapse rates" is false. This means that in the safety and efficacy study of lurasidone in the long term, lurasidone did not show high relapse rates.Rate this question:
-
- 6.
Name of the journal where the NMA(Network Meta Analysis) of Lurasidone Vs other antipsychotics was published?
-
World Health Organisation 2017
-
World Journal of Biological psychiatry 2017
-
Bipolar disorder 2017
-
International journal of bipolar disorder 2017
Correct Answer
A. World Journal of Biological psychiatry 2017Explanation
The correct answer is "World Journal of Biological psychiatry 2017". This journal is likely to be the one where the NMA of Lurasidone Vs other antipsychotics was published, as it specifically focuses on biological psychiatry and publishes research in this field.Rate this question:
-
- 7.
Full form of CGI-BPS.?
-
Clinical global impression - blood pressure scale
-
Clinical global impression - bipolar scale
-
Clinical global impression - binary scale
-
Clinical global impression -British pharmacopoeia
Correct Answer
A. Clinical global impression - bipolar scaleExplanation
CGI-BPS stands for Clinical Global Impression - Bipolar Scale. This scale is used in clinical research and practice to assess the severity of illness and overall improvement in patients with bipolar disorder. It involves rating the patient's condition on a scale from 1 to 7, with 1 indicating normal, not ill, and 7 indicating extremely ill. The CGI-BPS helps clinicians and researchers in evaluating the effectiveness of treatments and tracking the progress of patients with bipolar disorder.Rate this question:
-
- 8.
In the NMA study lurasidone had better efficacy compared to Aripiprazole & Ziprasidone.?
-
True
-
False
Correct Answer
A. TrueExplanation
The NMA study found that lurasidone had better efficacy compared to both Aripiprazole and Ziprasidone. This suggests that lurasidone was more effective in treating the condition or symptoms being studied than the other two medications.Rate this question:
-
- 9.
In the NMA study Olanzapine & Quetiapine had lesser weight gain compared to Lurasidone.?
-
True
-
False
Correct Answer
A. FalseExplanation
The given statement is false. The NMA study shows that Olanzapine & Quetiapine had greater weight gain compared to Lurasidone.Rate this question:
-
- 10.
In the NMA study lurasidone was having less somnolence compared to Quetiapine & Ziprasidone.?
-
True
-
False
Correct Answer
A. TrueExplanation
The NMA study found that lurasidone had less somnolence compared to both Quetiapine and Ziprasidone. This means that lurasidone is associated with less drowsiness or sleepiness as a side effect compared to the other two medications. Therefore, the statement "lurasidone was having less somnolence compared to Quetiapine & Ziprasidone" is true based on the findings of the NMA study.Rate this question:
-
Quiz Review Timeline (Updated): Jun 17, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
-
Current Version
-
Jun 17, 2023Quiz Edited by
ProProfs Editorial Team -
Jun 14, 2017Quiz Created by
SUJIT
Back to top